Oral Aztreonam ( DrugBank: Aztreonam )


1 disease
IDDisease name (Link within this page)Number of trials
299Cystic fibrosis1

299. Cystic fibrosis


Clinical trials : 1,696 Drugs : 1,644 - (DrugBank : 272) / Drug target genes : 96 - Drug target pathways : 170
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02730793
(ClinicalTrials.gov)
January 20173/11/2015Aztreonam Aerosol to Treat Cystic Fibrosis Nasal DiseaseAztreonam Aerosol to Treat Cystic Fibrosis Nasal DiseaseCystic FibrosisDrug: Oral Aztreonam;Drug: Nasal Aztreonam;Drug: Nasal PlaceboVirginia Commonwealth UniversityEastern Virginia Medical SchoolCompleted7 Years100 YearsAll10Phase 2United States